Clinical trials
Parkinsonism clinical trials
Below are recruiting parkinsonism clinical trials, each written for real people, not researchers. We’re tracking 735 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07599696Recruiting
Speech Amplification Devices for Parkinson Disease
This research study tests special amplification devices designed to help people with Parkinson disease or related conditions speak more clearly. The goal is to improve how well others can understand your speech.
East Lansing, MichiganAges 50 years+ - NCT07568951Recruiting
Hip Muscle Strength Study in Parkinson's Disease
This study compares how hip muscles work in people with and without Parkinson's disease. Researchers will measure your hip muscle strength and control to better understand how Parkinson's affects movement and balance.
TaoyuanAges 20–85 - NCT07567794Recruiting
Gut-Brain Connection Study in Parkinson's Disease
This research examines how the gut and brain are connected in Parkinson's disease and aims to better understand the disease. You'd participate in visits and tests over three years, including some involving your digestive system.
Stanford, CaliforniaAges 21–80 - NCT06730074Recruiting
Robotic exercise for Parkinson's motor and thinking skills
This study tests a new robotic system that combines movement and mental exercises for people with Parkinson's. It may help improve both your physical and thinking skills.
Ofakim, SouthAges 50–75 - NCT07554833Recruiting
Brain Stimulation for Parkinson's Motor and Memory Skills
This study tests whether repeated magnetic stimulation (rTMS) of the brain can help improve movement and thinking problems in people with Parkinson's disease. Researchers will measure how the treatment affects your motor control and cognitive function over the study period.
San Francisco, CaliforniaAges 50–90 - NCT07422675RecruitingPhase 1
Study of a new treatment for Parkinson's with motor fluctuations
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
Englewood, ColoradoAges 40–80 - NCT07411664Enrolling by invitation
Balance and walking study for stroke, Parkinson's, or multiple sclerosis
This study uses special motion-tracking tools to measure balance and trunk control in people with first-time stroke, Parkinson’s, or multiple sclerosis. It aims to understand how these conditions affect stability, which could help tailor rehabilitation.
Kaposvár, Somogy CountyAges 18–80 - NCT07386015Recruiting
Study of freezing of gait in Parkinson's disease
This study looks at people with Parkinson's disease or similar conditions who have walking problems like freezing of gait (feet feeling stuck) or balance issues. Researchers want to learn more about what causes these symptoms and how they affect people over time.
Tianjin, Tianjin MunicipalityAges 30–85 - NCT07371338RecruitingPhase 1
Testing a new drug for advanced Parkinson's
This trial tests an investigational drug called IPS101A in people with advanced Parkinson's disease. It aims to see if the drug is safe and how well it works when standard treatments are no longer enough.
SeoulAges 50–80 - NCT06203106Recruiting
NYSCF Scientific Discovery Biobank
This study collects blood, saliva, or skin samples from people with certain neurological conditions and from healthy volunteers to help researchers better understand and find treatments for these diseases.
New York, New YorkAges 4 weeks+ - NCT07330258Recruiting
Observing Parkinson's over time in people still having movement symptoms
This study follows people with Parkinson's disease who still have movement symptoms despite taking medication. It aims to understand how the disease changes over time, which could help improve future treatments.
Phoenix, ArizonaAges 45–75 - NCT07316296RecruitingPhase 3
Testing a drug to reduce freezing of gait in Parkinson's
This trial tests whether atomoxetine, a drug that boosts a brain chemical called noradrenaline, can help reduce freezing of gait—a feeling of your feet being stuck to the ground—in people with Parkinson's disease. You would continue your usual Parkinson's medications during the study and undergo walking tests and brain scans to see if the drug helps.
Nijmegen, GelderlandAges 18 years+ - NCT07316751Recruiting
Italian GIDS-PD Scale Validation for Parkinson's
This trial aims to translate and validate an Italian version of a scale that measures functional independence in people with Parkinson's disease. By participating, you will help ensure the scale is accurate and useful for Italian-speaking patients.
MilanAges 18 years+ - NCT07312110RecruitingPhase 2
D-Serine for slowing Parkinson's disease progression
This study tests whether a supplement called D-serine can slow the progression of Parkinson's disease. It is for people diagnosed within the last 5 years who have mild to moderate symptoms and are not yet dependent on a wheelchair.
Arendal, AgderAges 40–80 - NCT07278297Enrolling by invitation
Parkinson ballroom fitness: dance for better movement and mood
This study tests whether personalized ballroom dancing can help improve both motor (movement) and nonmotor (mood, thinking) symptoms in people with Parkinson's. You would attend dance classes and testing sessions, possibly with a caregiver or family member.
Viborg, Central JutlandAges 40 years+ - NCT07265596RecruitingPhase 2
Brain Scan Study for Early Parkinson's Disease
This trial uses a special brain scan (PET scan) to look at early changes in people who have early signs of Parkinson's disease. The goal is to learn more about how Parkinson's develops over time.
New Haven, ConnecticutAges 18 years+ - NCT07226284Recruiting
Testing a nerve stimulation device for leg movement in Parkinson's
This study tests if a device that stimulates the vagus nerve (a nerve in your neck) can improve leg muscle activity and walking balance in people with Parkinson's disease. You would participate in experiments while wearing the device to see how it affects your movement.
Minneapolis, MinnesotaAges 21–76 - NCT07207096Recruiting
Study of complementary medicine for Parkinson's disease
This study looks at patients with Parkinson's disease who visit a clinic that offers complementary medicine (like natural therapies). It aims to learn more about their experiences and health outcomes.
LondonAges 18 years+ - NCT04848077Recruiting
Smartphone exercise program for early Parkinson’s patients
This trial tests whether a motivating phone-based exercise plan can help people with early-stage Parkinson’s move more safely and consistently. You may qualify if you can walk on your own, understand Dutch, and are fairly inactive right now.
Nijmegen, GelderlandAges 18 years+ - NCT06949865Recruiting
AI-enhanced levodopa challenge test for parkinsonism
This study uses artificial intelligence (AI) to improve a standard test for parkinsonism called the levodopa challenge test. It may help doctors better understand how your movement symptoms respond to levodopa, a common Parkinson's medication.
BeijingAges 50–75 - NCT07154511RecruitingPhase 1/Phase 2
Tributyrin for Parkinson's with memory problems
This trial tests a supplement called tributyrin to see if it can help with thinking and memory problems in people with Parkinson's disease. You may be able to join if you have both Parkinson's and mild cognitive impairment or dementia.
Ann Arbor, MichiganAges 45 years+ - NCT06859528Recruiting
Walking program for people with Parkinson's disease
This study tests a community-based walking program designed for people with Parkinson's disease. It aims to see if regular walking can help improve movement and overall well-being.
St Louis, MissouriAges 30–85 - NCT07023224Recruiting
Turkish Parkinson's Dyskinesia Scale Reliability Study
This study is testing a Turkish version of a scale that measures dyskinesias (involuntary, jerky movements caused by Parkinson's medication). If you have Parkinson's, experience dyskinesias, and are at a mild to moderate stage, you may be able to help researchers see if the translated scale works well.
Izmir, İ̇zmi̇rAges Any age - NCT07020026RecruitingPhase 2
Tau brain scan study for Parkinson's and related disorders
This study uses a special PET scan to measure tau protein buildup in the brain of people with Parkinson's disease (including those with a LRRK2 gene mutation), Progressive Supranuclear Palsy, or Corticobasal Syndrome. It aims to better understand how tau relates to these conditions.
New Haven, ConnecticutAges 45–85
Hear when a new Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinsonism?
- Yes. Clin2 currently lists 735 recruiting parkinsonism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinsonism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinsonism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.